CRISPR Therapeutics AG (CRSP): Price and Financial Metrics
CRISPR Therapeutics AG (CRSP)
Today's Latest Price: $58.33 USD
1.30 (-2.18%)
Updated Jan 17 4:00pm
Add CRSP to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
CRSP Stock Summary
- Price to trailing twelve month operating cash flow for CRSP is currently 132.16, higher than 97.4% of US stocks with positive operating cash flow.
- With a price/sales ratio of 15.49, CRISPR Therapeutics AG has a higher such ratio than 92.4% of stocks in our set.
- Revenue growth over the past 12 months for CRISPR Therapeutics AG comes in at 501.94%, a number that bests 98.61% of the US stocks we're tracking.
- Stocks that are quantitatively similar to CRSP, based on their financial statements, market capitalization, and price volatility, are VYGR, SRRK, JNCE, SPRO, and CANF.
- Visit CRSP's SEC page to see the company's official filings. To visit the company's web site, go to crisprtx.com.
CRSP Daily Price Range
CRSP 52-Week Price Range
CRSP Stock Price Chart More Charts
CRSP Price/Volume Stats
| Current price | $58.33 | 52-week high | $74.00 |
| Prev. close | $59.63 | 52-week low | $29.34 |
| Day low | $57.81 | Volume | 1,116,590 |
| Day high | $60.28 | Avg. volume | 1,136,858 |
| 50-day MA | $62.79 | Dividend yield | N/A |
| 200-day MA | $48.39 | Market Cap | 3.22B |
CRISPR Therapeutics AG (CRSP) Company Bio
CRISPR Therapeutics AG focuses on the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene-editing platform. The company is based in Basel, Switzerland.
Top Stories View All
3 Vital Investing Strategies
Best & Worst Performing Stock Industries for January 17, 2020
Best & Worst Performing Small Cap Stocks for January 17, 2020
Best & Worst Performing Mid Cap Stocks for January 17, 2020
Best & Worst Performing Large Cap Stocks for January 17, 2020
View All Top Stories
Loading social stream, please wait...